Skip to main content
Fanli Digital Technology Co., Ltd logo

Fanli Digital Technology Co., Ltd — Investor Relations & Filings

Ticker · 600228 ISIN · CNE000000Y78 Shanghai Stock Exchange Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 2,251 across all filing types
Latest filing 2020-06-16 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600228

About Fanli Digital Technology Co., Ltd

https://corp.fanli.com/

Fanli Digital Technology Co., Ltd. provides e-commerce integration and digital marketing services. The company operates a comprehensive platform that connects consumers with various online retail ecosystems through value-added services such as cash-back rewards, discount coupons, and promotional insights. Its core business model focuses on performance-based marketing, utilizing data-driven strategies to facilitate sales conversions for brand partners. Key offerings include brand promotion, user loyalty management, and targeted advertising solutions. By integrating diverse shopping channels into a single interface, the company optimizes the consumer purchasing journey and provides brands with scalable traffic acquisition tools. The platform serves as a strategic intermediary, leveraging user behavioral data to enhance marketing efficiency and provide measurable returns for merchants while delivering cost savings to a broad user base.

Recent filings

Filing Released Lang Actions
关于延期回复《关于对公司重大资产置换、发行股份及支付现金购买资产并募集配套资金暨关联交易预案信息披露的问询函》的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from a company regarding the delay in responding to an inquiry letter from the Shanghai Stock Exchange about a major asset restructuring and related transactions. It references multiple previous announcements and states that the company is applying for an extension to reply to the inquiry letter. The document does not contain financial statements or detailed financial data but is rather a regulatory update about the status of the inquiry response and related procedural matters. It is short (1451 characters) and serves as a regulatory announcement rather than a full report or financial disclosure. Therefore, it fits best under Regulatory Filings (RNS).
2020-06-16 Chinese
2019年年度股东大会资料
AGM Information Classification · 95% confidence The document is titled as the 2019 Annual General Meeting (AGM) materials for 江西昌九生物化工股份有限公司, dated June 29, 2020. It contains the agenda, meeting procedures, and detailed reports submitted for shareholder approval, including the 2019 Board of Directors work report, Supervisory Board report, 2019 financial statements, profit distribution plan, and the 2019 annual report and summary. The content is comprehensive and includes detailed financial data, management reports, and governance information presented for discussion and voting at the AGM. This matches the definition of AGM Information (AGM-R), which includes presentations and materials shared during the Annual General Meeting. The document is not merely an announcement or a brief summary but the actual meeting materials. Therefore, the correct classification is AGM-R with high confidence.
2020-06-12 Chinese
关于完成法定代表人变更登记并换发营业执照的公告
Board/Management Information Classification · 100% confidence The document is an announcement regarding the completion of the legal representative change registration and the issuance of a new business license for the company. It includes details about the new legal representative, company registration information, and references to board meeting resolutions confirming the change. There is no financial data, no mention of financial results, no detailed report content, and the document is relatively short (852 characters). This fits the category of Board/Management Information (MANG), as it announces a change in the company's board or senior management (legal representative).
2020-06-12 Chinese
关于延期回复《关于对公司重大资产置换、发行股份及支付现金购买资产并募集配套资金暨关联交易预案信息披露的问询函》的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Jiangxi Changjiu Biochemical Co., Ltd. regarding the delay in responding to an inquiry letter from the Shanghai Stock Exchange about a major asset swap, share issuance, cash payment for asset purchase, and related party transaction plan. It references multiple previous announcements and states that the company is applying for an extension to reply to the inquiry letter. The document does not contain financial statements or detailed financial data but is a regulatory update about the status of a disclosure and response process. It is a regulatory announcement related to compliance and disclosure obligations rather than a financial report or audit report itself.
2020-06-09 Chinese
关于召开2019年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about the convening of the 2019 Annual General Meeting (AGM) of shareholders for Jiangxi Changjiu Bio-chemical Co., Ltd. It includes details such as the date, voting methods, meeting agenda, and instructions for shareholders to attend and vote. It does not contain the actual annual report or financial statements but rather information about the meeting where such reports will be discussed and voted on. The document length is 3620 characters, which is relatively short and consistent with a meeting notice rather than a full report. Therefore, this document fits the category of AGM Information (AGM-R).
2020-06-02 Chinese
关于延期回复《关于对公司重大资产置换、发行股份及支付现金购买资产并募集配套资金暨关联交易预案信息披露的问询函》的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Jiangxi Changjiu Biochemical Co., Ltd. regarding the delay in responding to an inquiry letter from the Shanghai Stock Exchange about a major asset swap, issuance of shares, cash payment for asset purchase, and related-party transaction disclosure. It references multiple previous announcements and states that the company has applied for an extension to reply to the inquiry letter. The document does not contain financial statements or detailed financial data but is a regulatory update about the status of a disclosure and response process. It is short (1489 characters) and serves as a progress update rather than a full report or financial filing. Therefore, it fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance update.
2020-06-02 Chinese

Browse filings by year

28 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.